EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 135 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.57 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $290,000 | -27.0% | 10,984 | +23.0% | 0.00% | 0.0% |
| Q2 2022 | $397,000 | -11.4% | 8,933 | -1.2% | 0.00% | 0.0% |
| Q1 2022 | $448,000 | -9.1% | 9,041 | -6.7% | 0.00% | 0.0% |
| Q4 2021 | $493,000 | -92.4% | 9,692 | -87.6% | 0.00% | -93.3% |
| Q1 2017 | $6,503,000 | -22.9% | 78,412 | -26.2% | 0.02% | -25.0% |
| Q4 2016 | $8,430,000 | +31.9% | 106,256 | +16.4% | 0.02% | +33.3% |
| Q3 2016 | $6,389,000 | +42.0% | 91,275 | -21.3% | 0.02% | +36.4% |
| Q2 2016 | $4,500,000 | +19.4% | 116,020 | +24.6% | 0.01% | +22.2% |
| Q1 2016 | $3,770,000 | -49.7% | 93,108 | +10.3% | 0.01% | -47.1% |
| Q4 2015 | $7,488,000 | +76.4% | 84,450 | +47.3% | 0.02% | +88.9% |
| Q3 2015 | $4,246,000 | +33.9% | 57,350 | +46.3% | 0.01% | +50.0% |
| Q2 2015 | $3,170,000 | – | 39,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |